Total Payments
$4,415
2024 Payments
$174.42
Companies
41
Transactions
328
Medicare Patients
3,001
Medicare Billing
$259,606
Payment Breakdown by Category
Food & Beverage$4,328 (98.0%)
Other$86.70 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,328 | 323 | 98.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $86.70 | 5 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $553.26 | 34 | $0 (2024) |
| Biogen, Inc. | $530.17 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $461.53 | 35 | $0 (2019) |
| Supernus Pharmaceuticals, Inc. | $444.00 | 67 | $0 (2020) |
| UCB, Inc. | $310.28 | 24 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $205.26 | 20 | $0 (2019) |
| Amgen Inc. | $190.31 | 10 | $0 (2020) |
| Upsher-Smith Laboratories LLC | $146.11 | 10 | $0 (2019) |
| Allergan Inc. | $132.81 | 19 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $121.05 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $174.42 | 7 | ABBVIE INC. ($38.04) |
| 2023 | $453.51 | 25 | AbbVie Inc. ($358.43) |
| 2022 | $37.62 | 2 | ABBVIE INC. ($37.62) |
| 2021 | $161.62 | 7 | AbbVie Inc. ($90.95) |
| 2020 | $125.45 | 6 | UCB, Inc. ($30.77) |
| 2019 | $1,268 | 87 | Novartis Pharmaceuticals Corporation ($171.54) |
| 2018 | $996.44 | 77 | Novartis Pharmaceuticals Corporation ($167.97) |
| 2017 | $1,198 | 117 | UCB, Inc. ($167.96) |
All Payment Transactions
328 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: Neurology | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ARGENX US, INC. | VYVGART (Drug), VYVGART HYTRULO | Food and Beverage | In-kind items and services | $31.48 | General |
| Category: Immunology | ||||||
| 07/08/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $37.59 | General |
| 05/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: PAIN | ||||||
| 01/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $31.01 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: PAIN | ||||||
| 07/20/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 648 | 725 | $142,434 | $58,267 |
| 2022 | 8 | 730 | 807 | $159,443 | $64,202 |
| 2021 | 9 | 798 | 871 | $177,987 | $74,288 |
| 2020 | 9 | 825 | 939 | $179,573 | $62,849 |
Total Patients
3,001
Total Services
3,342
Medicare Billing
$259,606
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 261 | 301 | $45,150 | $18,607 | 41.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 159 | 180 | $38,160 | $17,747 | 46.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 100 | 100 | $32,100 | $11,807 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 48 | 52 | $5,096 | $2,293 | 45.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 23 | 23 | $5,681 | $2,169 | 38.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $6,192 | $2,066 | 33.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $3,915 | $1,448 | 37.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 24 | $3,312 | $1,413 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 14 | $2,828 | $716.08 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 271 | 311 | $46,650 | $19,447 | 41.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 164 | 181 | $38,433 | $17,608 | 45.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 109 | 109 | $34,989 | $12,576 | 35.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 32 | $12,384 | $4,682 | 37.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 42 | 59 | $8,142 | $3,146 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 57 | 59 | $5,782 | $2,661 | 46.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $4,959 | $1,906 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 23 | $4,646 | $1,093 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 14 | 14 | $3,458 | $1,085 | 31.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 180 | 206 | $43,672 | $20,255 | 46.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 264 | 293 | $43,950 | $19,458 | 44.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 123 | 123 | $39,483 | $14,823 | 37.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 36 | 36 | $13,932 | $5,349 | 38.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 39 | 39 | $10,179 | $3,823 | 37.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 52 | 66 | $9,108 | $3,592 | 39.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 24 | 24 | $5,928 | $2,378 | 40.1% |
About Dr. Heike Schmolck, MD
Dr. Heike Schmolck, MD is a Neurology healthcare provider based in Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1972646917.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heike Schmolck, MD has received a total of $4,415 in payments from pharmaceutical and medical device companies, with $174.42 received in 2024. These payments were reported across 328 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($4,328).
As a Medicare-enrolled provider, Schmolck has provided services to 3,001 Medicare beneficiaries, totaling 3,342 services with total Medicare billing of $259,606. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Des Moines, IA
- Active Since 02/15/2007
- Last Updated 02/24/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1972646917
Products in Payments
- TROKENDI XR (Drug) $395.89
- TYSABRI (Biological) $339.29
- UBRELVY (Drug) $283.03
- GILENYA (Drug) $268.55
- Briviact (Drug) $267.05
- QULIPTA (Drug) $242.01
- Aimovig (Biological) $153.65
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $146.11
- APTIOM (Drug) $121.05
- ADUHELM (Biological) $107.71
- NAMZARIC (Drug) $99.40
- COPAXONE (Drug) $81.34
- GOCOVRI (Drug) $80.31
- Mavenclad (Biological) $79.17
- ACTHAR (Biological) $75.36
- Betaseron (Drug) $74.41
- INBRIJA (Drug) $70.29
- Zembrace (Drug) $69.46
- MAYZENT (Drug) $67.27
- EMGALITY (Drug) $61.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Des Moines
Bruce Hughes, Md, MD
Neurology — Payments: $2.3M
Neurology $2.3M
Michael Jacoby, Md, MD
Neurology — Payments: $247,801
Neurology $247,801
Lynn Rankin, Md, MD
Neurology — Payments: $222,800
Neurology $222,800
Paul Babikian, Md, MD
Neurology — Payments: $162,701
Neurology $162,701
Wendy Zadeh, Md, MD
Neurology — Payments: $138,438
Neurology $138,438
Mark Puricelli, Do, DO
Neurology — Payments: $70,851
Neurology $70,851